Subgroup | Reference | SOR | Tests for heterogeneity | ||
---|---|---|---|---|---|
(95% CI) | Q | P | I 2(%) | ||
Geographic region | |||||
Asia | 1.05 (1.03-1.08)â–³ | 30.7 | <0.001* | 90 | |
Asia# | 1.04 (1.01-1.06)â–³ | 1.76 | 0.42 | 0.00 | |
Western | 1.17 (1.11-1.22)â–³ | 0.64 | 0.724 | 0.00 | |
Population | |||||
Healthy people | 2.59 (2.07-3.23)â–² | 6.08 | 0.02* | 69 | |
Diabetic | 1.90 (1.30-2.78)â–² | 0.07 | 0.79 | 0 | |
Sex | |||||
Male | 1.43 (1.05-1.94)â–³ | 32.98 | 0.001* | 94 | |
Female | 1.21 (1.04-1.41)â–³ | 4.57 | 0.07 | 63 | |
Follow-up | |||||
<5 years | 1.03 (1.01-1.06)â–³ | 0.19 | 0.66 | 0 | |
2.49 (1.79-3.46)â–² | 2.99 | 0.08 | 67 | ||
≥5 years | 1.09 (1.04-1.14)△ | 2.63 | 0.45 | 0 | |
2.64 (2.09-3.32)â–² | 6.48 | 0.09 | 54 |